Method for conjugation of biomolecules and new use of gold donor for biomolecular complex formation
A technology of biomolecules and complexes, which is applied to the preparation methods of peptides, medical preparations of non-active ingredients, chemical instruments and methods, etc., and can solve problems such as toxicity of nanoparticles and obstacles to in vivo application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0073] TRAP complex Preparation - Reaction with Au-TPPMS
[0074] (See figure 1 )
[0075] Gold compound:
[0076] [Diphenyl (3-sulfonate] phosphine] Chloride (I), sodium salt hydrate (Au-TPPMS, MDL MFCD19443491) is purchased from STREM CHEMICALS UK, LIMITED, and achieved by dissolving in water The desired concentration (usually 5 mm). The gold nanoparticles (GNP) used are a diphenyl group (mexylphenyl) phosphine having 1-3 nm inner diameter from StREM CHEMICALS UK (MDL MFCD 17018839).
[0077] TRAP preparation:
[0078] The protein used to successfully use Au-TPPMS is a TRAP protein having introduced cysteine. Expression and purification of TRAP containing 35 residual lysine (K) to cysteine and 64 residual argin (R) to serine (S) Additional mutation (called "TRAP-CS ") And the aforementioned TRAP-CS 11 (As described in detail above), significant changes are TCEP (three (2-carboxyethyl) phosphine) is not included in the cracking step. The final buffer is usually 20 mM Tris-HCl,...
Embodiment 2
[0083] Preparation of TRAP Composites - Reaction with Au (I) - Trobenzylphosphine
[0084] Trobhenylphosphine chloride (I) (Au-TPP, figure 1 B) A similar reaction instead of Au-TPPMS. The Au-TPP was dissolved in DMSO, reacted in 50 mM Tris, 150 mM NaCl, pH 7.9 and Au-TPP, and DMSO did not exceed 10% of the final volume, and the TRAP monomer was present at a concentration of about 1 mm. The ratio of Au-TPP and TRAP is 4: 2 to 4: 3. This also results in a TRAP cage formed from the same structure obtained in the Au-TPPMS reaction. The amount of the reagent is adjusted separately. The ratio and reaction conditions of the TRAP monomer / gold donor were the same as where Au-TPPMs was reacted as a gold donor.
[0085] Two embodiments having different halogen (triaryl phosphine) gold (I) gold donor reagents were carried out above. It shows a halogen (triaryl phosphine) gold (I) having a different aryl moiety (I) is adapted to form a complex according to the present invention.
Embodiment 3
[0087] Use Cryo-EM to confirm the TRAP complex structure
[0088] The initial (low resolution) Cryo-EM structure of the Trap cage was obtained using a Cryo-EM single particle recombination technique for using a TRAP cage formed using GNP. 10,11 And the structure data is used as an initial model of the high resolution Cryo-EM structure formed in the TRAP cage formed in the reaction in the reaction in the reaction in the reaction in accordance with the present invention.
[0089] The structure of the TRAP cage was resolved using Cryo-EM to 3.9 angstroms. This is sufficient to display the arrangement of 24 TRAP loops and demonstrate that there is a connection density (specified as AU) between the crystallysite chains of the relative ring (see figure 2 ).
[0090] figure 2 Examples of the gold sewing reaction and the formation of the complex are exemplified. figure 2 A shows the structure of a single TRAP ring (PDB4V4F) that is displayed in two mutually orthogonal views. The mutat...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com